Epidemiology

Clinical trials of biosimilars should become more similar
Jonathan Kay, John D Isaacs

Annals of the Rheumatic Diseases Jan 2017, 76 (1) 4-6; DOI: 10.1136/annrheumdis-2015-208113
Response to: ‘Monocyte type I interferon signature in antiphospholipid syndrome is related to pro-inflammatory monocyte subsets, hydroxychloroquine and statin use’ by van den Hoogen et al
Srilakshmi Yalavarthi, Robert C Grenn, Jason S Knight

Annals of the Rheumatic Diseases Dec 2016, 75 (12) e82; DOI: 10.1136/annrheumdis-2016-210529
Association between rheumatoid arthritis disease activity, progression of functional limitation and long-term risk of orthopaedic surgery: combined analysis of two prospective cohorts supports EULAR treat to target DAS thresholds
Elena Nikiphorou, Sam Norton, Adam Young, Lewis Carpenter, Josh Dixey, David Andrew Walsh, Patrick Kiely

Annals of the Rheumatic Diseases Dec 2016, 75 (12) 2080-2086; DOI: 10.1136/annrheumdis-2015-208669
Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density
Corinne Klop, Frank de Vries, Johannes W J Bijlsma, Hubert G M Leufkens, Paco M J Welsing

Annals of the Rheumatic Diseases Dec 2016, 75 (12) 2095-2100; DOI: 10.1136/annrheumdis-2015-208958
Ultrasonographic evaluation in psoriatic arthritis is of major importance in evaluating disease activity
Brigitte Michelsen, Andreas P Diamantopoulos, Hilde B Hammer, Dag M Soldal, Arthur Kavanaugh, Glenn Haugeberg

Annals of the Rheumatic Diseases Dec 2016, 75 (12) 2108-2113; DOI: 10.1136/annrheumdis-2015-208806
Complex disease=complex trial? Lessons from a successful trial of anti-IFNα in SLE
Ronald van Vollenhoven

Annals of the Rheumatic Diseases Nov 2016, 75 (11) 1899-1901; DOI: 10.1136/annrheumdis-2016-209345
Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts
S Ajeganova, J H Humphreys, M K Verheul, H W van Steenbergen, J A B van Nies, I Hafström, B Svensson, T W J Huizinga, L A Trouw, S M M Verstappen, A H M van der Helm-van Mil

Annals of the Rheumatic Diseases Nov 2016, 75 (11) 1924-1932; DOI: 10.1136/annrheumdis-2015-208579
Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials
Kun Zou, Jean Wong, Natasya Abdullah, Xi Chen, Toby Smith, Michael Doherty, Weiya Zhang

Annals of the Rheumatic Diseases Nov 2016, 75 (11) 1964-1970; DOI: 10.1136/annrheumdis-2015-208387
Does flare trial design affect the effect size of non-steroidal anti-inflammatory drugs in symptomatic osteoarthritis? A systematic review and meta-analysis
Toby O Smith, Kun Zou, Natasya Abdullah, Xi Chen, Sarah R Kingsbury, Michael Doherty, Weiya Zhang, Philip G Conaghan

Annals of the Rheumatic Diseases Nov 2016, 75 (11) 1971-1978; DOI: 10.1136/annrheumdis-2015-208823
Predicting improvement in diffuse scleroderma: lessons learnt
Janet E Pope

Annals of the Rheumatic Diseases Oct 2016, 75 (10) 1741-1742; DOI: 10.1136/annrheumdis-2016-209116

Main menu

Epidemiology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Epidemiology

Pages